ArticleScientific reports2026
Stochastic LASSO for extremely high-dimensional genomic data.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- SurvMarker: an R package for identifying survival-associated molecular features using PCA-based weighted scores.BMC bioinformatics · 2026Article
- Proteomic signatures of life's essential 8 and incident atrial fibrillation among individuals with chronic kidney disease.Nutrition & metabolism · 2026Article
- Machine learning-based diagnostic models for prevalent metabolic syndrome among patients with disuse muscle atrophy: a comparative study of seven algorithms.Frontiers in endocrinology · 2026Article
- Plasma proteomics reveals the molecular features in rapidly progressive pneumoconiosis.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate identification of significant features in high-dimensional data is indispensable in high-throughput genomic analysis and association studies. Least Absolute Shrinkage and Selection Operator (LASSO) and its derivatives have been widely adapted to discover potential biomarkers as a feature selection scheme in various biological systems. Recently, bootstrap-based LASSO models, such as Random LASSO and Hi-LASSO, have been effective solutions for extremely high-dimensional but low sample size (EHDLSS) genomic data. However, the bootstrap-based LASSO models still have several drawbacks, such as multicollinearity within bootstrap samples, missing predictors in draw, and randomness in predictor sampling. To tackle the limitations, we propose a new bootstrap-based LASSO, named Stochastic LASSO, that effectively reduces multicollinearity in bootstrap samples and mitigates randomness in predictor sampling, resulting in remarkably outperforming benchmarks in feature selection and coefficient estimation. Furthermore, Stochastic LASSO provides a two-stage t-test strategy for selecting statistically significant features. The performance of Stochastic LASSO was assessed by comparing the existing benchmark models in extensive simulation experiments. In the simulation experiments, Stochastic LASSO consistently showed significant improvements in performance compared to the state-of-the-art LASSO models for feature selection, coefficient estimation, and robustness. We also applied Stochastic LASSO for the gene expression data of publicly available TCGA cancer datasets and identified statistically significant genes associated with survival month prediction. The source code is publicly available at: https://github.com/datax-lab/StochasticLASSO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.